Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a Bayesian network meta-analysis

BACKGROUND: Despite numerous immunotherapy and chemotherapy regimens available for patients with extensive-stage small cell lung cancer (ES-SCLC), it remains unclear which regimen is the most effective and safest; relative studies comparing such regimens are scarce. OBJECTIVE: The aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tianming, Li, Wenjun, Diwu, Danbei, Chen, Lijun, Chen, Xi, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331819/
https://www.ncbi.nlm.nih.gov/pubmed/37435087
http://dx.doi.org/10.3389/fimmu.2023.1197044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331819/
https://www.ncbi.nlm.nih.gov/pubmed/37435087
http://dx.doi.org/10.3389/fimmu.2023.1197044

Ejemplares similares